Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Taro Pharmaceutical Industries ROE 2010-2023 | TARO

Current and historical return on equity (ROE) values for Taro Pharmaceutical Industries (TARO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
  
Taro Pharmaceutical Industries ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-12-31 $0.05B $1.78B 2.63%
2023-09-30 $0.03B $1.75B 1.90%
2023-06-30 $0.02B $1.74B 1.22%
2023-03-31 $0.03B $1.73B 1.46%
2022-12-31 $0.05B $1.72B 2.63%
2022-09-30 $0.06B $1.71B 3.75%
2022-06-30 $0.09B $1.71B 5.30%
2022-03-31 $0.06B $1.71B 3.38%
2021-12-31 $-0.00B $1.70B 0.00%
2021-09-30 $0.01B $1.67B 0.41%
2021-06-30 $0.03B $1.66B 1.70%
2021-03-31 $-0.39B $1.70B -22.63%
2020-12-31 $-0.30B $1.75B -16.71%
2020-09-30 $-0.27B $1.72B -14.16%
2020-06-30 $-0.26B $1.67B -13.04%
2020-03-31 $0.24B $2.11B 11.92%
2019-12-31 $0.25B $2.07B 12.42%
2019-09-30 $0.27B $2.03B 14.12%
2019-06-30 $0.28B $1.98B 13.91%
2019-03-31 $0.28B $1.91B 13.45%
2018-12-31 $0.31B $1.85B 14.28%
2018-09-30 $0.23B $2.35B 10.35%
2018-06-30 $0.22B $2.28B 10.02%
2018-03-31 $0.21B $2.21B 9.58%
2017-12-31 $0.21B $2.20B 9.59%
2017-09-30 $0.33B $2.21B 15.61%
2017-06-30 $0.40B $2.15B 19.70%
2017-03-31 $0.46B $2.07B 23.10%
2016-12-31 $0.49B $2.00B 25.15%
2016-09-30 $0.54B $1.92B 27.90%
2016-06-30 $0.55B $1.92B 29.53%
2016-03-31 $0.54B $1.94B 30.83%
2015-12-31 $0.58B $1.94B 35.57%
2015-09-30 $0.53B $1.62B 36.09%
2015-06-30 $0.54B $1.53B 39.55%
2015-03-31 $0.48B $1.42B 38.42%
2014-12-31 $0.42B $1.32B 36.36%
2014-09-30 $0.40B $1.20B 37.09%
2014-06-30 $0.35B $1.09B 33.96%
2014-03-31 $0.36B $1.02B 36.57%
2013-12-31 $0.32B $0.95B 33.52%
2013-09-30 $0.29B $1.04B 31.53%
2013-06-30 $0.26B $0.94B 30.50%
2013-03-31 $0.27B $0.89B 33.41%
2012-12-31 $0.26B $0.85B 36.20%
2012-09-30 $0.24B $0.76B 35.91%
2012-06-30 $0.23B $0.69B 38.79%
2012-03-31 $0.20B $0.62B 37.83%
2011-12-31 $0.18B $0.57B 37.44%
2011-09-30 $0.13B $0.50B 28.36%
2011-06-30 $0.09B $0.46B 21.82%
2011-03-31 $0.07B $0.42B 20.09%
2010-12-31 $0.05B $0.38B 17.61%
2010-09-30 $0.06B $0.30B 22.69%
2010-06-30 $0.05B $0.26B 20.60%
2010-03-31 $0.04B $0.25B 18.57%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.587B $0.573B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.403B 28.11
Chugai Pharmaceutical (CHGCY) Japan $55.239B 23.99
Takeda Pharmaceutical (TAK) Japan $42.345B 6.86
Merck (MKGAF) Germany $20.744B 19.57
Astellas Pharma (ALPMY) Japan $17.174B 24.33
Shionogi (SGIOY) Japan $14.546B 12.59
Sandoz Group AG (SDZNY) Switzerland $14.473B 0.00
Neurocrine Biosciences (NBIX) United States $13.940B 57.89
United Therapeutics (UTHR) United States $11.034B 11.82
Catalent (CTLT) United States $10.140B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.624B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.909B 7.01
Ionis Pharmaceuticals (IONS) United States $6.098B 0.00
Revolution Medicines (RVMD) United States $5.972B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.345B 0.00
Alpine Immune Sciences (ALPN) United States $4.231B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.078B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.946B 0.00
Evotec AG (EVO) Germany $2.711B 0.00
Summit Therapeutics (SMMT) United States $2.617B 0.00
Indivior (INDV) United States $2.569B 11.94
Corcept Therapeutics (CORT) United States $2.394B 24.21
Dyne Therapeutics (DYN) United States $2.192B 0.00
PTC Therapeutics (PTCT) United States $1.947B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.915B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.807B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.738B 17.96
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.658B 9.82
Avadel Pharmaceuticals (AVDL) Ireland $1.639B 0.00
Ardelyx (ARDX) United States $1.487B 0.00
Soleno Therapeutics (SLNO) United States $1.341B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.301B 12.22
4D Molecular Therapeutics (FDMT) United States $1.269B 0.00
Pacira BioSciences (PCRX) United States $1.247B 12.41
Collegium Pharmaceutical (COLL) United States $1.175B 7.23
Xencor (XNCR) United States $1.123B 0.00
Cronos Group (CRON) Canada $0.944B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.943B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.903B 0.00
Cassava Sciences (SAVA) United States $0.889B 0.00
USANA Health Sciences (USNA) United States $0.861B 13.56
ARS Pharmaceuticals (SPRY) United States $0.820B 0.00
Enliven Therapeutics (ELVN) United States $0.813B 0.00
Sage Therapeutics (SAGE) United States $0.778B 0.00
Relay Therapeutics (RLAY) United States $0.774B 0.00
Ocular Therapeutix (OCUL) United States $0.774B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Silence Therapeutics (SLN) United Kingdom $0.674B 0.00
Savara (SVRA) United States $0.648B 0.00
Siga Technologies (SIGA) United States $0.623B 9.22
Lyell Immunopharma (LYEL) United States $0.622B 0.00
ProKidney (PROK) United States $0.580B 0.00
Verve Therapeutics (VERV) United States $0.575B 0.00
Korro Bio (KRRO) United States $0.545B 0.00
OmniAb (OABI) United States $0.543B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.542B 0.00
Altimmune (ALT) United States $0.537B 0.00
Exscientia (EXAI) United Kingdom $0.529B 0.00
KalVista Pharmaceuticals (KALV) United States $0.473B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.448B 0.00
Heron Therapeutics (HRTX) United States $0.421B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.400B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.397B 0.00
Esperion Therapeutics (ESPR) United States $0.396B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Tourmaline Bio (TRML) United States $0.387B 0.00
Nature's Sunshine Products (NATR) United States $0.372B 20.81
Harrow (HROW) United States $0.365B 0.00
Bioventus (BVS) United States $0.341B 0.00
Aquestive Therapeutics (AQST) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.314B 0.00
Lyra Therapeutics (LYRA) United States $0.311B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
ESSA Pharma (EPIX) Canada $0.283B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.278B 0.00
Nanobiotix S.A (NBTX) France $0.269B 0.00
Metagenomi (MGX) United States $0.263B 0.00
Pyxis Oncology (PYXS) United States $0.262B 0.00
Nektar Therapeutics (NKTR) United States $0.261B 0.00
Black Diamond Therapeutics (BDTX) United States $0.259B 0.00
Adherex Technologies (FENC) United States $0.250B 0.00
Xeris Biopharma Holdings (XERS) United States $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.232B 0.00
Avita Medical (RCEL) United States $0.231B 0.00
Conduit Pharmaceuticals (CDT) United States $0.229B 0.00
Acrivon Therapeutics (ACRV) United States $0.222B 0.00
Foghorn Therapeutics (FHTX) United States $0.220B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Galectin Therapeutics (GALT) United States $0.209B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.200B 0.00
Zevra Therapeutics (ZVRA) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.188B 0.00
Telomir Pharmaceuticals (TELO) United States $0.172B 0.00
MediWound (MDWD) Israel $0.156B 0.00
Achieve Life Sciences (ACHV) Canada $0.154B 0.00
CytoDyn (CYDY) United States $0.149B 0.00
Regulus Therapeutics (RGLS) United States $0.148B 0.00
Incannex Healthcare (IXHL) Australia $0.145B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.132B 2.79
VAXART, INC (VXRT) United States $0.132B 0.00
Elite Pharmaceuticals (ELTP) United States $0.132B 12.32
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Inotiv (NOTV) United States $0.125B 0.00
Citius Pharmaceuticals (CTXR) United States $0.122B 0.00
GlycoMimetics (GLYC) United States $0.118B 0.00
Relmada Therapeutics (RLMD) United States $0.118B 0.00
OptiNose (OPTN) United States $0.109B 0.00
FibroGen (FGEN) United States $0.106B 0.00
Eliem Therapeutics (ELYM) United States $0.104B 0.00
Vivani Medical (VANI) United States $0.099B 0.00
ProPhase Labs (PRPH) United States $0.093B 0.00
PMV Pharmaceuticals (PMVP) United States $0.093B 0.00
AlloVir (ALVR) United States $0.091B 0.00
Aclaris Therapeutics (ACRS) United States $0.087B 0.00
Assertio Holdings (ASRT) United States $0.087B 7.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.071B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.062B 0.00
SCYNEXIS (SCYX) United States $0.059B 0.87
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.055B 0.00
BioLineRx (BLRX) Israel $0.051B 0.00
Jaguar Animal Health (JAGX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
JanOne (JAN) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
Unicycive Therapeutics (UNCY) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
CASI Pharmaceuticals (CASI) China $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
VYNE Therapeutics (VYNE) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Nutriband (NTRB) United States $0.028B 0.00
DURECT (DRRX) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.93
MEI Pharma (MEIP) United States $0.022B 1.12
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Addex Therapeutics (ADXN) Switzerland $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.90